CHEMORADIOTHERAPY
Clinical trials for CHEMORADIOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new CHEMORADIOTHERAPY trials appear
Sign up with your email to follow new studies for CHEMORADIOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to shrink rectal tumors before surgery
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (PD-1 inhibitor) to a standard treatment plan (short-course radiation, chemotherapy, and a targeted therapy) can improve outcomes for people with locally advanced rectal cancer. About 104 participants will receive the standard…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
Breakthrough trial may let rectal cancer patients keep their rectum without surgery
Disease control Recruiting nowThis study tests whether a combination of chemotherapy and radiation before surgery (total neoadjuvant therapy) can help about half of rectal cancer patients achieve a complete response, allowing them to avoid surgery and preserve their rectum through a watch-and-wait strategy. T…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug aims to shield cancer patients from chemo side effect
Disease control Recruiting nowThis study tests a drug called mecapegfilgrastim in 30 adults with lung or esophageal cancer who are getting chemotherapy and radiation. The goal is to see if it can safely prevent or reduce myelosuppression, a condition where the body makes fewer blood cells. Participants will b…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Affiliated Hospital of Nantong University • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New combo therapy aims to shrink untreatable esophageal tumors
Disease control Recruiting nowThis study tests whether adding the drug surufatinib to standard chemotherapy, immunotherapy, and radiation can help people with advanced esophageal cancer that cannot be removed by surgery. The goal is to see if this combination can keep the cancer from growing for at least two …
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 06, 2026 16:01 UTC
-
New drug combo aims to stop esophageal cancer recurrence after standard treatment
Disease control Recruiting nowThis phase 3 trial tests whether adding two drugs—toripalimab (an immunotherapy) and capecitabine (a chemotherapy pill)—after standard chemoradiation can help prevent esophageal cancer from coming back. About 242 adults with advanced esophageal cancer that hasn't spread after ini…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 28, 2026 13:08 UTC
-
Scientists test aggressive Four-Pronged attack on Fast-Moving lung cancer
Disease control Recruiting nowThis study is testing whether adding two newer drugs, toripalimab and surufatinib, to the standard treatment of chemotherapy and radiation can better control limited-stage small cell lung cancer. It will involve about 47 adults with this specific type of cancer that has not sprea…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 20, 2026 16:14 UTC
-
Can better nutrition improve cancer survival? new study investigates
Knowledge-focused Recruiting nowThis study follows 1,538 cancer patients in China to see how their nutritional status affects their response to chemotherapy and radiation. Researchers will track changes in diet, weight, and quality of life over time. The goal is to find ways to use nutrition to improve treatmen…
Matched conditions: CHEMORADIOTHERAPY
Sponsor: Xiaoqin Luo • Aim: Knowledge-focused
Last updated May 17, 2026 02:00 UTC
-
Nationwide audit to ensure cervical cancer patients get the right treatment
Knowledge-focused Recruiting nowThis study looks at whether hospitals in India are following standard guidelines for treating cervical cancer with radiation and chemotherapy. Researchers will review records from over 600 patients across many hospitals to see how often the recommended treatment is given correctl…
Matched conditions: CHEMORADIOTHERAPY
Sponsor: Tata Memorial Hospital • Aim: Knowledge-focused
Last updated May 05, 2026 11:54 UTC